Articles and Information
Form 7 Monthly Progress Report June 2025
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
July 8, 2025
- News
BioMark Receives NSERC Engage Grant for Raman Enhancement with Dr. SAFIEDDIN SAFAVI-NAEINI
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
News
Press Release – BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology
Novel Graph Neural Network (N-GNN) Model Achieves Superior Accuracy in Early Lung Cancer Detection, Paving
June 3, 2025
Articles and Information
Form 7 Monthly Progress Report May 2025
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
June 3, 2025
News
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability
May 13, 2025
News
BioMark Diagnostics Announces Uplisting to OTCQB Venture Market
Milestone strengthens transparency and credibility as the Company advances commercialization of its metabolomics technology platform
May 10, 2025
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2